
Opinion|Videos|March 28, 2025
Balancing Approved Therapies and Patient Preference in Parkinson Disease
Author(s)Daniel E. Kremens, MD, JD
An expert discusses the importance of collaborating with patients, emphasizing the value of leading with data when educating them on the efficacy of treatments, and highlights the role of providers in supporting patients as they discover the medications and supplements that work best for them, while advocating for and protecting patients to ensure they can seek the best quality of life.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Rethinking Clinical Trial Design and the Immune System in Multiple Sclerosis: Ahmed Obeidat, MD, PhD
2
AAIC 2026 Preview: David Wolk, MD, on Biomarkers, Disease Heterogeneity, and What's Next in Alzheimer Research
3
Rituximab Noninferior to Ocrelizumab in Newly Diagnosed Relapsing MS, Head-to-Head Trial Finds
4
AbobotulinumtoxinA, Ublituximab Meet Primary End Points, Serum Protein Signature May Predict Relapse in NMOSD
5















